Nanomanipulation of Ligand Nanogeometry Modulates Integrin/Clathrin-Mediated Adhesion and Endocytosis of Stem Cells
Source abstract
Abstract
Nanosubstrate engineering can be a biomechanical approach for modulating stem cell differentiation in tissue engineering. However, the study of the effect of clathrin-mediated processes on manipulating this behavior is unexplored. Herein, we develop integrin-binding nanosubstrates with confined nanogeometries that regulate clathrin-mediated adhesion- or endocytosis-active signaling pathways for modulating stem fates. Isotropically presenting ligands on the nanoscale enhances the expression of clathrin in cells, thereby facilitating uptake of dexamethasone-loaded nanoparticles (NPs) to boost osteogenesis of stem cells. In contrast, anisotropic ligand nanogeometry suppresses this clathrin-mediated NP entry by strengthening the association between clathrin and adhesion spots to reinforce mechanotransduced signaling, which can be abrogated by the pharmacological inhibition of clathrin. Meanwhile, inhibiting focal adhesion formation hinders cell spreading and enables a higher endocytosis efficiency. Our findings reveal the crucial roles of clathrin in both endocytosis and mechanotransduction of stem cells and provide the parameter of ligand nanogeometry for the rational design of biomaterials for tissue engineering.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Cellular Mechanics and Interactions · Cell Adhesion Molecules Research · Cellular transport and secretion
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering, The Hong Kong Polytechnic University, Kowloon, Hong Kong 999077, China
Research Institute for Sports Science and Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong 999077, China
Funding
Research Grants Council, University Grants Committee · Hong Kong Polytechnic University · Guangdong-Hong Kong Technology Cooperation Funding Scheme · Shenzhen Science and Technology Program-Basic Research Scheme
References (62)
Show source-provided references
1. 10.1021/acsami.0c1766410.1021/acsami.0c17664 ↗
2. 10.1186/s12951-017-0310-510.1186/s12951-017-0310-5 ↗
3. 10.1021/nn101373r10.1021/nn101373r ↗
4. 10.1021/acsbiomaterials.2c0002610.1021/acsbiomaterials.2c00026 ↗
5. 10.1016/j.jconrel.2009.12.02410.1016/j.jconrel.2009.12.024 ↗
6. 10.3390/cryst1107072810.3390/cryst11070728 ↗
7. 10.1126/sciadv.aba838110.1126/sciadv.aba8381 ↗
8. 10.1021/acs.nanolett.0c0493210.1021/acs.nanolett.0c04932 ↗
9. 10.1021/acs.nanolett.1c0193410.1021/acs.nanolett.1c01934 ↗
10. 10.1021/acs.nanolett.9b0146810.1021/acs.nanolett.9b01468 ↗
11. 10.1038/nnano.2017.9810.1038/nnano.2017.98 ↗
12. 10.1021/nl400033h10.1021/nl400033h ↗
13. 10.1039/D2NR03792K10.1039/D2NR03792K ↗
14. 10.1126/science.aal471310.1126/science.aal4713 ↗
15. 10.1038/ncomms1606810.1038/ncomms16068 ↗
16. 10.1038/ncomms967210.1038/ncomms9672 ↗
17. 10.1038/s41467-018-06367-y10.1038/s41467-018-06367-y ↗
18. 10.1083/jcb.20181116010.1083/jcb.201811160 ↗
19. 10.1016/j.biomaterials.2013.03.06510.1016/j.biomaterials.2013.03.065 ↗
20. 10.3389/fmolb.2021.62701510.3389/fmolb.2021.627015 ↗
21. 10.1016/j.nantod.2010.10.00710.1016/j.nantod.2010.10.007 ↗
22. 10.1016/j.biomaterials.2011.08.08810.1016/j.biomaterials.2011.08.088 ↗
23. 10.1016/j.biomaterials.2018.10.00210.1016/j.biomaterials.2018.10.002 ↗
24. 10.1021/acs.nanolett.5b0161910.1021/acs.nanolett.5b01619 ↗
25. 10.1021/acs.nanolett.8b0515010.1021/acs.nanolett.8b05150 ↗
26. 10.1002/smll.20210432810.1002/smll.202104328 ↗
27. 10.1002/adma.20130176210.1002/adma.201301762 ↗
28. 10.1016/j.biomaterials.2013.01.02110.1016/j.biomaterials.2013.01.021 ↗
29. 10.1021/nl504986210.1021/nl5049862 ↗
30. 10.1002/advs.20220447910.1002/advs.202204479 ↗
31. 10.3390/jcs601001910.3390/jcs6010019 ↗
32. 10.1021/acs.nanolett.6b0495810.1021/acs.nanolett.6b04958 ↗
33. 10.1021/acs.nanolett.9b0531510.1021/acs.nanolett.9b05315 ↗
34. 10.1016/j.colsurfb.2020.11143910.1016/j.colsurfb.2020.111439 ↗
35. 10.1002/adfm.20180682210.1002/adfm.201806822 ↗
36. 10.1021/nl103943u10.1021/nl103943u ↗
37. 10.1021/la201938u10.1021/la201938u ↗
38. 10.1002/smll.20160148310.1002/smll.201601483 ↗
39. 10.1021/la502954210.1021/la5029542 ↗
40. 10.1002/smll.20210737310.1002/smll.202107373 ↗
41. 10.1021/acsnano.9b0642410.1021/acsnano.9b06424 ↗
42. 10.1039/C3NR06433F10.1039/C3NR06433F ↗
43. 10.1002/smll.20210268310.1002/smll.202102683 ↗
44. Devi G. R. · Indo Am. J. Pharm. Res. · 2013 · 3 · 5055
45. 10.3389/fmolb.2021.70071210.3389/fmolb.2021.700712 ↗
46. 10.1039/C8SC02842G10.1039/C8SC02842G ↗
47. 10.1016/j.actbio.2021.08.05310.1016/j.actbio.2021.08.053 ↗
48. 10.1038/mt.2009.28110.1038/mt.2009.281 ↗
49. 10.1371/journal.pone.010632810.1371/journal.pone.0106328 ↗
50. 10.1016/j.biomaterials.2010.06.02510.1016/j.biomaterials.2010.06.025 ↗
51. 10.1002/cbic.20110043710.1002/cbic.201100437 ↗
52. 10.1021/acs.nanolett.9b0476110.1021/acs.nanolett.9b04761 ↗
53. 10.1002/advs.20220459410.1002/advs.202204594 ↗
54. 10.1016/S0142-9612(02)00052-210.1016/S0142-9612(02)00052-2 ↗
55. 10.1038/s41467-021-23120-010.1038/s41467-021-23120-0 ↗
56. 10.1038/s41467-021-26454-x10.1038/s41467-021-26454-x ↗
57. 10.1073/pnas.101675810810.1073/pnas.1016758108 ↗
58. 10.1186/s40035-015-0041-110.1186/s40035-015-0041-1 ↗
59. 10.1016/j.jconrel.2018.12.01410.1016/j.jconrel.2018.12.014 ↗
60. 10.1128/MCB.20.23.8783-8792.200010.1128/MCB.20.23.8783-8792.2000 ↗
61. 10.1016/j.cej.2019.04.01710.1016/j.cej.2019.04.017 ↗
62. 10.1016/S0005-2736(97)00027-810.1016/S0005-2736(97)00027-8 ↗